Division of Cancer Prevention and Control, National Center for Chronic Disease Prevention and Health Promotion, Centers for Disease Control and Prevention, Atlanta, Georgia.
Division of Cancer Control and Population Sciences, National Cancer Institute, Rockville, Maryland.
Am J Prev Med. 2019 Jan;56(1):66-73. doi: 10.1016/j.amepre.2018.07.030. Epub 2018 Nov 19.
Prior studies suggest overuse of nonrecommended lung cancer screening tests in U.S. community practice and underuse of recommended tests.
Data from the 2010 and 2015 National Health Interview Surveys was analyzed from 2016 to 2018. Prevalence, populations, and number of chest computed tomography (CT) and chest x-ray tests were estimated for people who did and did not meet U.S. Preventive Services Task Force (USPSTF) criteria for lung cancer screening, among people aged ≥40 years without lung cancer.
In 2015, among those who met USPSTF criteria, 4.4% (95% CI=3.0%, 6.6%), or 360,000 (95% CI=240,000, 535,000) people reported lung cancer screening with a chest CT; and 8.5% (95% CI=6.5%, 11.1%), or 689,000 (95% CI=526,000, 898,000) people reported a chest x ray. Among those who did not meet USPSTF criteria, 2.3% (95% CI=2.0%, 2.6%), or 3,259,000 (95% CI=2,850,000, 3,724,000) people reported a chest x ray; and 1.3% (95% CI=1.1%, 1.5%), or 1,806,000 (95% CI=1,495,000, 2,173,000) people reported a chest CT. The estimated population meeting USPSTF criteria for lung cancer screening in 2015 was 8,098,000 (95% CI=7,533,000, 8,702,000), which was smaller than the 9,620,000 people (95% CI=8,960,000, 10,325,000) in 2010.
The number of adults inappropriately screened for lung cancer greatly exceeds the number screened according to USPSTF recommendations, the prevalence of appropriate lung cancer screening is low, and the population meeting USPSTF criteria is shrinking. To realize the potential benefits of screening, better processes to appropriately triage eligible individuals to screening, plus screening with a USPSTF-recommended test, would be beneficial.
先前的研究表明,美国社区实践中过度使用了非推荐的肺癌筛查检测,而对推荐的检测则使用不足。
对 2016 年至 2018 年来自 2010 年和 2015 年全国健康访谈调查的数据进行了分析。在没有肺癌的 40 岁及以上人群中,根据美国预防服务工作组(USPSTF)的肺癌筛查标准,对符合和不符合标准的人群进行了胸部计算机断层扫描(CT)和胸部 X 线检查的流行率、人群和数量估计。
2015 年,在符合 USPSTF 标准的人群中,有 4.4%(95%CI=3.0%,6.6%),即 36 万人(95%CI=24 万,53.5 万)进行了胸部 CT 肺癌筛查;有 8.5%(95%CI=6.5%,11.1%),即 68.9 万人(95%CI=52.6 万,89.8 万)进行了胸部 X 线检查。在不符合 USPSTF 标准的人群中,有 2.3%(95%CI=2.0%,2.6%),即 325.9 万人(95%CI=285 万,372.4 万)进行了胸部 X 线检查;有 1.3%(95%CI=1.1%,1.5%),即 180.6 万人(95%CI=149.5 万,217.3 万)进行了胸部 CT 检查。2015 年符合 USPSTF 肺癌筛查标准的估计人口为 809.8 万人(95%CI=753.3 万,870.2 万),小于 2010 年的 962 万人(95%CI=896 万,1032.5 万)。
不适当进行肺癌筛查的成年人数量大大超过了根据 USPSTF 建议进行筛查的人数,适当肺癌筛查的流行率较低,符合 USPSTF 标准的人群正在缩小。为了实现筛查的潜在益处,更好的方法是适当将符合条件的个人分诊到筛查中,并使用 USPSTF 推荐的检测方法进行筛查。